MétaCan
Menu
Back to cohort
Record W2763504758 · doi:10.24870/cjb.2017-a16

Drug targets and lipid biomarkers of hyperlipidemia associated diseases

2017· article· en· W2763504758 on OpenAlexvenueno aff
Sneha Rai, Sonika Bhatnagar

Bibliographic record

VenueCanadian Journal of Biotechnology · 2017
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
Fundersnot available
KeywordsHyperlipidemiaDrugMedicinePharmacologyDiabetes mellitusEndocrinology

Abstract

fetched live from OpenAlex

Hyperlipidemia (HL) is characterized by elevated level of plasma lipids affecting regular functioning of lipid-protein interactions leading to disease. The traditional lipid biomarkers utilized for detection of individuals with HL and Cardiovascular Diseases (CVD) risk, sometimes fail to predict future CVD events therefore, establishing need of novel lipid biomarkers for CVD detection. It was attempted to predict the lipid biomarkers using systems biology and by a meta-analysis of lipidomics studies. A lipid-protein-protein interaction network (LPPIN) was built by incorporating differentially expressed genes in fatty liver of obese subjects obtained from Gene Expression Omnibus, with the interacting lipids obtained from STITCH database. The protein interactions were derived using PathwayLinker and lipid interactions were acquired from STITCH 4.0. For identification of novel lipid biomarkers comparative analysis of normolipidemic, hyperlipidemic and CVD lipid profile was conducted. Cholesterol, diacylglycerol, phosphatidylinositol-bis-phosphate and inositol-triphosphate were central to LPPIN, therefore had the largest systemic effect. The choke point analysis identified proteins having maximum interactions with network lipids, malfunctioning of which could lead to HL associated diseases. Cluster analysis recognized CVD, cancer, Alzheimer's disease and type-2-diabetes to be linked with HL. Lipids associated with the disease clusters consisted of triacylglycerol, cholesterol, oleic acid, linoleic acid, arachidonic acid, palmitate, inositol triphosphate, inositol-1,4-bisphosphate and phosphatidinositol-4-phosphate. Approved HL drug targets like Proprotein Convertase Subtilisin Kexin Type 9 and Niemann-Pick C1-Like 1 may be repurposed for treatment of hyperlipidemia associated diseases. Using a combination of gene prioritization and bridging centrality, Coactosin-like binding protein 1, Vasodilator stimulated phosphoprotein and Hedgehog acyltransferase were identified as a potential drug target for CVD, cancer and Alzheimer's, respectively. A comparative lipidomics analysis revealed that palmitoyl-lysophosphatidylcholine level was decreased while plasma level of free fatty acids and ceramides were elevated in HL and CVD. Both HL and CVD were associated with changes in lipid composition. HL was associated with increased level of saturated diacylglycerol, triacylglycerol and phospholipids while CVD was associated with increase in small chain fatty acids with low double bond content in triacylglycerol, cholesteryl ester and sphingomyelin. Our work highlights new drug targets and biomarkers for hyperlipidemia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.239
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueCanadian Journal of BiotechnologySame topicLipoproteins and Cardiovascular HealthFrench-language works237,207